VALUE-Dx

VALUE-Dx is dedicated to advancing healthcare through innovative diagnostic solutions. As a collaborative initiative uniting leading in vitro diagnostic companies and non-industry partners, VALUE-Dx is at the forefront of combating antimicrobial resistance (AMR) and enhancing patient outcomes. The multidisciplinary approach of VALUE-Dx integrates the expertise of clinicians, microbiologists, health economists, social scientists, and industry professionals to build a robust medical and economic framework that supports the adoption of rapid diagnostics as a crucial public health tool in the fight against antibiotic resistance.

Focusing on community care settings, VALUE-Dx aims to transform clinical practices by introducing innovative diagnostics that reduce uncertainties in antibiotic prescriptions. This targeted approach is particularly relevant to Community-Acquired Acute Respiratory Tract Infections, where the majority of antibiotics are prescribed. By improving diagnostic strategies, VALUE-Dx seeks to optimize antibiotic use, thereby minimizing the spread of AMR and improving overall patient care.

VALUE-Dx is committed to driving significant advancements in the healthcare sector through cutting-edge diagnostic solutions. We invite the management team at VALUE-Dx to further enrich our platform with a customized company showcase and detailed product listings, highlighting your contributions to the fight against antimicrobial resistance.